SCHEMBL7429505

SCHEMBL7429505

CCOC(=O)N1C(=O)CC(C)(C)c2cc(C3=NNC(=O)SC3C)ccc21

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 12/20 0.48
PDE3A Q14432 12/20 0.48
PDE4A P27815 8/20 0.48
PDE4B Q07343 8/20 0.48
PDE4C Q08493 8/20 0.48
PDE4D Q08499 8/20 0.48
KCNH2 Q12809 1/20 0.41
FBP1 P09467 1/20 0.35
GPR119 Q8TDV5 1/20 0.34
RXRA P19793 3/20 0.32
RARA P10276 1/20 0.32
RARB P10826 1/20 0.32
RARG P13631 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7428441 0.86 PDE3B (0.53) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7377678 0.79 PDE3B (0.49) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7381719 0.78 PDE3B (0.50) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7375763 0.77 PDE3B (0.49) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7377312 0.76 PDE3B (0.48) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7379251 0.76 PDE4A (0.48) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7431591 0.75 PDE3B (0.58) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7429508 0.74 PDE3B (0.50) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7429294 0.74 PDE3B (0.57) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL7381427 0.74 PDE3B (0.57) PDE3BPDE3APDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0303418-A2 Substituted indolones, useful in the treatment of heart or asthmatic diseases SMITHKLINE BEECHAM LABORATOIRES PHARMACEUTIQUES (FR) 1989-02-15 EP claimed
US-4933336-A Thiadiazinone, oxadiazinone and triazinone derivatives, and their use for treating acute or chronic heart disease LABORATOIRES SOBIO S.A. (FR) 1990-06-12 US disclosed
EP-0303418-A2 Substituted indolones, useful in the treatment of heart or asthmatic diseases SMITHKLINE BEECHAM LABORATOIRES PHARMACEUTIQUES (FR) 1989-02-15 EP disclosed